Literature DB >> 869627

Myocardial revascularization and carotid endarterectomy: a combined approach.

J E Okies, Q MacManus, A Starr.   

Abstract

The approach to the patient with combined carotid and coronary artery occlusive disease has been evolving since corornary bypass procedures became feasible. When neurological and cardiac symptoms are remote, sequential procedures are adequate. Neurological symptoms or severe carotid stenoses (or both) appearing simultaneously with symptoms of myocardial ischemia present a more difficult problem. Simultaneous operation has been performed in 16 patients with 1 early death (low output) and 2 cerebral complications (1 patient with residual hand weakness and 1 without neurological risidua). The morbidity and mortality seemed unrelated to the fact that procedures were done at one operation. Therapy, however, must be tailored to the individual patient.

Entities:  

Mesh:

Year:  1977        PMID: 869627     DOI: 10.1016/s0003-4975(10)63702-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Vascular reconstructive surgery following myocardial revascularization.

Authors:  W H Edwards; J L Mulherin; W E Walker
Journal:  Ann Surg       Date:  1978-06       Impact factor: 12.969

2.  Concomitant carotid and coronary artery reconstruction.

Authors:  J M Craver; D A Murphy; E L Jones; P E Curling; D K Bone; R B Smith; G D Perdue; C R Hatcher; M Kandrach
Journal:  Ann Surg       Date:  1982-06       Impact factor: 12.969

3.  Carotid endarterectomy without temporary intraluminal shunt. Study of 309 consecutive operations.

Authors:  D A Ott; D A Cooley; L Chapa; A Coelho
Journal:  Ann Surg       Date:  1980-06       Impact factor: 12.969

4.  Impact of patients´ age on short and long-term outcome after carotid endarterectomy and simultaneous coronary artery bypass grafting.

Authors:  Mona Salehi Ravesh; Rene Rusch; Christine Friedrich; Christoph Teickner; Rouven Berndt; Assad Haneya; Jochen Cremer; Thomas Pühler
Journal:  J Cardiothorac Surg       Date:  2019-06-15       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.